The latest quarterly R&D expense is $0 with a QoQ Growth of -100.00%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $0.00.
$0
$0
Q2 FY2026 · 2026-06-30
-100.00%
vs. $23.86M prior quarter
19
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $0 | -100.00% | -100.00% |
| Q1 FY2026Period end 2026-03-31 | $23.86M | +15.89% | +40.98% |
| Q4 FY2025Period end 2025-12-31 | $20.59M | -8.61% | +17.59% |
| Q3 FY2025Period end 2025-09-30 | $22.53M | +17.70% | +37.03% |
| Q2 FY2025Period end 2025-06-30 | $19.14M | +13.09% | +27.60% |
| Q1 FY2025Period end 2025-03-31 | $16.92M | -3.34% | +13.67% |
| Q4 FY2024Period end 2024-12-31 | $17.51M | +6.50% | +41.08% |
| Q3 FY2024Period end 2024-09-30 | $16.44M | +9.60% | +30.42% |
| Q2 FY2024Period end 2024-06-30 | $15.00M | +0.74% | +10.36% |
| Q1 FY2024Period end 2024-03-31 | $14.89M | +19.97% | +9.92% |
| Q4 FY2023Period end 2023-12-31 | $12.41M | -1.54% | N/A |
| Q3 FY2023Period end 2023-09-30 | $12.61M | -7.26% | N/A |
| Q2 FY2023Period end 2023-06-30 | $13.59M | +0.34% | N/A |
| Q1 FY2023Period end 2023-03-31 | $13.55M | N/A | N/A |
| Q4 FY2022Period end 2022-12-31 | $0 | N/A | N/A |
| Q3 FY2022Period end 2022-09-30 | $0 | N/A | N/A |
| Q2 FY2022Period end 2022-06-30 | $0 | N/A | N/A |
| Q1 FY2022Period end 2022-03-31 | $0 | N/A | N/A |
| Q4 FY2021Period end 2021-12-31 | $0 | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
